Back to Top Top research trainee finds molecular connection between obesity and anxiety - The Ottawa Hospital Website scanner for suspicious and malicious URLs
 

toh

Tags:

Top research trainee finds molecular connection between obesity and anxiety

 
Top research trainee finds molecular connection between obesity and anxiety

Postdoctoral fellow Dr. Zhaohong (Tina) Qin’s passion for mental health research led her to discover that the brain’s pathways for anxiety and obesity are linked, opening up possibilities for new treatments.

Some days Dr. Zhaohong (Tina) Qin has to remind herself to leave the lab and go home. She becomes so absorbed in watching neurons fire that she loses track of time.

”You apply the drug and you can see the change right away,” said the postdoctoral fellow at The Ottawa Hospital and the University of Ottawa. “I love it so much – nothing else makes me feel so alive.”

Dr. Qin was no stranger to research when she immigrated to Canada 11 years ago. In China she worked in the pharmaceutical industry, discovering new drugs and finding different ways to diagnose diseases.

“Research in mental health has the first place in my mind and heart,” Dr. Qin explained. “One of my best friends died by suicide. I want to use my skills to help treat these challenging conditions that affect so many people.”

During her PhD in Dr. Hsiao-Huei Chen’s lab, Dr. Qin made a surprising discovery. She found that a drug called trodusquemine, which controls weight gain, could also relieve anxiety in mice. This meant that somehow the brain pathways for anxiety and obesity were linked.

Right away, Dr. Qin wanted to find out why. After many additional tests and experiments, she found the reason: an enzyme called PTP1B. When it is overactive, this enzyme helps cause both anxiety and obesity. The drug trodusquemine lets the brain fix itself by bringing the levels of PTP1B back to normal.

“It’s our hope that this exciting finding can move to the clinic, and that this drug can be used to fight two diseases at once,” said Dr. Qin.

But Dr. Qin isn’t stopping there. She’s currently investigating whether this drug can also treat other mental health conditions that involve overactive PTB1B, such as Alzheimer’s disease and schizophrenia.

Praised by her colleagues for her strength, drive, independence and determination, Dr. Qin has published 12 research articles, many in high-impact journals such as Neuron and Journal of Neuroscience. Despite her successes, she will be the first to admit that a career in neuroscience can also be challenging.

“It’s easy to get frustrated when experiments fail, but I cannot give up,” said Dr. Qin. “If I want my research to help people, it can’t just stay in the lab.”

Dr. Qin has been selected as the hospital’s top research trainee of the year. She will be presented with the Worton Researcher in Training Award at The Ottawa Hospital Gala on Nov. 5.

 
Comment

You might also like…

This website gives you common facts, advice and tips. Some of it may not apply to you. Please talk to your doctor, nurse or other health-care team member to see if this information will work for you. They can also answer your questions and concerns.

WPML Translation ID: 819